BridgeMD
New treatment option for Anxiety
Official title Prediction of Anxiety and Memory State
ClinicalTrials.gov ID: NCT06551090
What this study is testing
- What it's testing
- The purpose of this study is to look at how signals in the brain, body, and behavior relate to anxiety and memory function. This project seeks to develop the CAMERA (Context-Aware Multimodal Ecological Research and Assessment) platform, a state-of-the-art open multimodal hardware/software system for measuring human brain-behavior relationships.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 55
You may be able to join if
- Patients must have known or suspected Temporal Lobe Epilepsy.
- Native or proficient in speaking English or Spanish.
- Stereoelectroencephalography (sEEG) cases: The implant plan must include hippocampal head, body, and tail electrodes either unilaterally or...
- 7th grade reading level (minimum level considered literate for adults)
You likely can't join if
- Hearing impaired (i.e., not corrected with a hearing aid)
- Unable to read the newspaper at arm's length with corrective lenses.
- Objective intellectual impairment (estimated IQ \< 70)
- Any history of Electroconvulsive Therapy or psychosis (except postictal psychosis for patients)
- Psychotic disorder (lifetime)
- Current Anxiety disorder, Major Depressive Disorder, or Bipolar Disorder
See the full eligibility criteria
- Patients must have known or suspected Temporal Lobe Epilepsy.
- Native or proficient in speaking English or Spanish.
- Stereoelectroencephalography (sEEG) cases: The implant plan must include hippocampal head, body, and tail electrodes either unilaterally or bilaterally.
- 7th grade reading level (minimum level considered literate for adults)
- Hearing impaired (i.e., not corrected with a hearing aid)
- Unable to read the newspaper at arm's length with corrective lenses.
- Objective intellectual impairment (estimated IQ \< 70)
- Any history of Electroconvulsive Therapy or psychosis (except postictal psychosis for patients)
- Psychotic disorder (lifetime)
- Current Anxiety disorder, Major Depressive Disorder, or Bipolar Disorder
- Neurodegenerative diseases, presence of widespread brain lesions, language problems (other than naming difficulty)
- Medical conditions that could potentially affect cognitive performance (e.g., human immunodeficiency virus (HIV) infection, cancer with metastatic potential).
- Acute renal failure or end-stage renal disease
The study team makes the final eligibility decision.
Where it's taking place
- New York, New York, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 55 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New York, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.